Summary:
Click image to enlargeTo access the efficacy in improving cognitive impairment using MCCB in patients with schizophrenia, treated for 26 weeks with BI 425809 as compared to placebo.
Qualified Participants Must:
• Adults aged 18 to 50
• Diagnosed at least 1-year withs schizophrenia stable on medication for at least 12 weeks on anti-psychotic medication
• woman of the childbearing age should be on birth control
• must be able to read, speak and write English
• willing and be to commit to meet all study requirements
Qualified Participants May Receive:
COMPENSATION FOR TIME AND TRAVEL